Laser speckle contrast imaging

Activ Surgical Announces Completion of First International Procedure Using Its ActivSight™ Intelligent Light

Retrieved on: 
Monday, January 22, 2024
Software, Pharmaceutical, Hardware, Robotics, Oncology, Medical Devices, Technology, Hospitals, Health Technology, Surgery, Biotechnology, Health, Patient, Laser speckle contrast imaging, Hospital, MD, DRS, Partnership, Intelligent lighting, MENA, Cancer, Foregut, Investment, Abdali Hospital, Surgeon, Bariatric surgery, Trial of the century

Activ Surgical , a digital surgery pioneer, announced that it has completed its first international surgery at Abdali Hospital , a member of the Clemenceau Network, in Amman, Jordan using its ActivSight™ Intelligent Light (ActivSight), which aims to provide enhanced visualization and real-time, on-demand surgical insights in the operating room.

Key Points: 
  • Activ Surgical , a digital surgery pioneer, announced that it has completed its first international surgery at Abdali Hospital , a member of the Clemenceau Network, in Amman, Jordan using its ActivSight™ Intelligent Light (ActivSight), which aims to provide enhanced visualization and real-time, on-demand surgical insights in the operating room.
  • ActivSight is an easy-to-adapt module that seamlessly attaches to today’s laparoscopic and robotic systems and integrates with standard monitors.
  • On December 24, 2023, Mohamad Rassoul Abu-Nuwar, MD, who specializes in general and advanced laparoscopic gastrointestinal surgery, foregut, as well as bariatric surgery, performed a surgical bariatric revision procedure using the ActivPerfusion™ Mode within ActivSight.
  • To date, multiple major hospital networks across the U.S. have purchased ActivSight, and many additional customer sites are planned for 2024.

Activ Surgical® Presented Findings from Colorectal Study Using its ActivSight™ Intelligent Light at the American Society of Colon and Rectal Surgeons Annual Scientific Meeting

Retrieved on: 
Monday, June 5, 2023
Technology, Surgery, Medical Devices, Hospitals, Health Technology, Software, Hardware, Health, Robotics, Ohio State University, Medicine, Surgeon, Laser speckle contrast imaging, Comparison, Rectum, Perfusion, Intelligent lighting, ASCRS, American Society of Colon and Rectal Surgeons, LOD, Doctor of Philosophy, Trial of the century, OSU, MD, Division, Ohio State University Wexner Medical Center, Patient safety, FDA, Society, ICG, Dissection, Medical imaging, Dentistry, Indocyanine green

Activ Surgical , a digital surgery pioneer, presented findings today at The American Society of Colon and Rectal Surgeons (ASCRS) Annual Scientific Meeting from a clinical study conducted at The Ohio State University Wexner Medical Center using the ActivPerfusion™ and ActivICG™ modes within its FDA cleared product, ActivSight™ Intelligent Light (ActivSight).

Key Points: 
  • Activ Surgical , a digital surgery pioneer, presented findings today at The American Society of Colon and Rectal Surgeons (ASCRS) Annual Scientific Meeting from a clinical study conducted at The Ohio State University Wexner Medical Center using the ActivPerfusion™ and ActivICG™ modes within its FDA cleared product, ActivSight™ Intelligent Light (ActivSight).
  • LSCI provides real-time tissue perfusion information by measuring coherent laser light scatter from moving red blood cells.
  • For cases where a decision was changed, the average discordance between the line of demarcation (LOD) in white light imaging and LSCI was 3.7cm.
  • “Less dissection and removal of tissue can improve patient safety and may lead to better surgical outcomes.”

DoIT of MOEA Created New Business Opportunities at TIE 2022

Retrieved on: 
Monday, October 17, 2022
Carbon, Physician, Time-invariant system, Medicine, Technology, Efficiency, Industrial Technology Research Institute, Biotechnology, Patient, Laser, Recycling, ITRI, NHRI, TIE, Multimedia, HAR, TSV, MOEA, Department, Laser speckle contrast imaging, Glass, National Health Research Institutes, Burn, Steel, Ministry, TGV, Digital, Exhibition, LCD, Industrial technology, Economy, Solution, Ministry of the economy, Doit, Renewable energy, Television, Online shopping

TAIPEI, Oct. 17, 2022 /PRNewswire/ -- The physical exhibition of Taiwan Innotech Expo 2022 (TIE 2022) has ended with great success. The Department of Industrial Technology (DoIT), Ministry of Economic Affairs (MOEA) curated the Discovering Technology Treasures exhibition at the Innovation Pilot pavilion, where 80 innovative technologies related to net-zero carbon emissions, sustainable development, electric cars, and biotechnology were on display. More than 40,000 visitors and nearly 100 companies participated in this event, sparking numerous business opportunities. In response to the call for net-zero emissions by 2050, many leading enterprises expressed their keen interest in solutions for carbon reduction and circular economy at the exhibition.

Key Points: 
  • TAIPEI, Oct. 17, 2022 /PRNewswire/ -- The physical exhibition of Taiwan Innotech Expo 2022 (TIE 2022) has ended with great success.
  • More than 40,000 visitors and nearly 100 companies participated in this event, sparking numerous business opportunities.
  • Two major highlights of the green solutions at TIE 2022 were the Laser-based Encapsulation Removal Process for LCD panels and the Digital Carbon-Emission Reduction Application Technology.
  • Among the smart healthcare solutions at TIE 2022 was the laser speckle contrast imaging (LSCI) system developed by the National Health Research Institute (NHRI).

DoIT focuses on electric vehicles and net-zero sustainable industries

Retrieved on: 
Friday, October 14, 2022
Hydrogen, Taipei, Technology, Efficiency, Technology transfer, Organization, Solution, Biotechnology, Patient, Hospital, Second Place, Ministry of Economic Affairs (Taiwan), Laser speckle contrast imaging, PCCU, ITRI, NHRI, World Trade Center, Multimedia, Institute, Information industry, Industry, Department, National Health Research Institutes, AI, World, Industrialisation, Burn, Ministry, Industrial technology, Economy, NTU, Doit, Fine chemical

TAIPEI, Oct. 13, 2022 /PRNewswire/ -- The Department of Industrial Technology (DoIT) under the Ministry of Economic Affairs today (Oct 13) kicked off the Discovering Technology Treasures exhibit at the Innovation Pilot pavilion at the 2022 Taiwan Innotech Expo. The exhibit, at the Taipei World Trade Center Hall 1,  features 80 innovative technologies that will drive the transformation and upgrading of Taiwan industry. These technologies, focusing on electric vehicles, net-zero sustainability, and biotechnology & medical care, have been selected from hundreds of achievements of technology development programs carried out by 14 non-profit R&D organizations, including ITRI, Institute for Information Industry, and National Health Research Institutes (NHRI). These organizations will work with domestic and foreign companies, incubating start-up teams and linking up with international markets, thereby successfully realizing a number of cooperation projects and forging new business opportunities for industry.

Key Points: 
  • DoIT Director General Chiou Chyou-Huey commented that the 80 technologies featured at the Discovering Technology Treasures exhibit have two major characteristics.
  • Secondly, these technologies will, on the basis of entrepreneurial thinking, help to cultivate new industries that can spark start-ups and business opportunities.
  • This is Taiwan's first example of successfully combining a vehicle controller and wire-based controller, and this technology serves as the core in enabling electric vehicles to start smoothly.
  • Many other innovative technologies promoted by the DoIT and being shown at the Taiwan Innotech Expo will promote new business opportunities in the biotechnology and medical care industries.

Contrast Security's Alliance Team Prepares for its Anticipated Growth with the Hiring of Three Industry Veterans and The Promotion of an Industry Expert

Retrieved on: 
Tuesday, October 11, 2022
Cloud, Micro ISV, Micro Focus, Deloitte, Culture, EMEA, VP, Public sector, Partner, Microsoft, Partnership, Senior, Technology, AWS, Software, LOS, Legacy Fighting Alliance in 2018, Ecosystem, GitHub, Corporate development, ForgeRock, Laser speckle contrast imaging, VMware, Airline, Google, Contrast

LOS ALTOS, Calif., Oct. 11, 2022 /PRNewswire/ -- Contrast Security (Contrast), the leader in code security that empowers developers to secure-as-they code, today announced it has hired three industry veterans and has promoted an internal expert to help drive technology, system integrators and integration engineering alliances and partnerships in North America and EMEA. The new hires, as well as the industry expert, will be part of the Partner Alliance Team as announced today by Contrast Security.

Key Points: 
  • The new hires, as well as the industry expert, will be part of the Partner Alliance Team as announced today by Contrast Security.
  • Most recently Vice President WW Security Alliances at Micro Focus, Mead will leverage her strong experience managing channels, partner enablement, and system integrators for Contrast.
  • At Contrast he will have similar responsibilities in addition to creating highly differentiated integrations with a rapidly growing group of partners.
  • Doing so enables application and development teams to collaborate more effectively and to innovate faster while accelerating digital transformation initiatives.

Sky Medical Technology wins further FDA clearance to market the new (W3) geko™ device variant for venous insufficiency and ischemia

Retrieved on: 
Friday, March 25, 2022
Artery, Journal, Manuscript, Calf, Elsevier, NMES, Microdeletion syndrome, Venous insufficiency, Venous thrombosis, Laser speckle contrast imaging, Walking, Patient, Leg, Internet, International College, Vein, Bosanquet, Common peroneal nerve, Ischemia, Food, Sky, Edema, Quality of life, CC, Health, Technology, Geko, Food and Drug Administration, Medtech, International Angiology, Knee, International, DOI, DVT, Founder, CVI, FDA, Chronic venous insufficiency, W2, Medical device, Birth control, Pulsatile insulin

This latest (W3) geko device 510(k) follows the company's prior 2021 FDA clearance for the (W2) geko device, also authorized for venous insufficiency and/or ischemia.

Key Points: 
  • This latest (W3) geko device 510(k) follows the company's prior 2021 FDA clearance for the (W2) geko device, also authorized for venous insufficiency and/or ischemia.
  • Venous insufficiency can progress to chronic venous insufficiency (CVI), a serious condition attributed to diminished quality of life and loss of work productivity.
  • If venous insufficiency and ischemia are left untreated, progression of CVI can lead to post-phlebitic syndrome and venous leg ulcers.
  • [i]
    Three recently published studies, by Das[ii],[iii] and Bosanquet[iv] demonstrate the geko device generates microcirculatory blood flow increase in the lower limbs of patients with venous insufficiency and ischemia.

Sky wins FDA clearance to market the geko™ device for venous insufficiency and ischemia - a therapy area sorely in need of innovation.

Retrieved on: 
Thursday, December 16, 2021
Manuscript, Common peroneal nerve, Food, FDA, Vein, Internet, DVT, Sky, Venous insufficiency, Knee, Health, Venous thrombosis, Artery, Geko, Journal, Edema, DOI, NMES, CVI, Patient, Quality of life, Leg, Elsevier, CC, International, Ischemia, Food and Drug Administration, Multimedia, International Angiology, Microdeletion syndrome, Calf, Partnership, Technology, International College, Laser speckle contrast imaging, Walking, View, Medical device, Birth control, Medical imaging, Pulsatile insulin

Venous insufficiency can progress to chronicvenous insufficiency(CVI), a serious condition attributed to diminished quality of life and loss of work productivity.

Key Points: 
  • Venous insufficiency can progress to chronicvenous insufficiency(CVI), a serious condition attributed to diminished quality of life and loss of work productivity.
  • If venous insufficiency and ischemia are left untreated, progressive to CVI can lead to post-phlebitic syndrome and venous leg ulcers1.
  • Three recent published studies, two led by Das2,3,the other led by Bosanquet4demonstrate geko device generated microcirculatory blood flow increase in the lower limbs of patients with venous insufficiency and ischemia.
  • CEO and Founder Bernard Ross said, "Achieving this latest 510(k) clearance is a significant milestone for Sky that will allow us to initiate a controlled market release of the geko device, to address venous insufficiency and ischemia in the first instance a therapy area sorely in need of innovation.

Global Veterinary Ultrasound Market by Type, Product, Technology, Animal Type, Application, End-user, and Region - Forecast to 2026 - ResearchAndMarkets.com

Retrieved on: 
Friday, November 26, 2021
Veterinary, Health, Cardiology, Growth, Adoption, GE Healthcare, Hospital, CAGR, Awareness, USD, Obstetrics, Fujifilm, Small, Laser speckle contrast imaging, Digital, Urbanization, Doppler effect, Medical imaging, Pet

The global veterinary ultrasound market is projected to reach USD 456 million by 2026 from USD 301 million in 2021, at a CAGR of 7% during the forecast period.

Key Points: 
  • The global veterinary ultrasound market is projected to reach USD 456 million by 2026 from USD 301 million in 2021, at a CAGR of 7% during the forecast period.
  • Based on the end user, the veterinary ultrasound market is into veterinary clinics, veterinary hospitals & academic institutes, and other end users.
  • In 2020, the veterinary clinics segment accounted for the largest share of the global veterinary ultrasound market.
  • The growth of veterinary clinics & hospitals in these countries has increased the demand for veterinary ultrasound market.